[PHARMA] QoQ Annualized Quarter Result on 31-Dec-2021 [#4]

Announcement Date
17-Feb-2022
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2021
Quarter
31-Dec-2021 [#4]
Profit Trend
QoQ- 48.96%
YoY- 526.25%
View:
Show?
Annualized Quarter Result
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Revenue 3,530,609 3,446,552 3,848,696 4,815,015 5,471,062 3,941,244 3,173,996 7.34%
PBT 76,732 83,920 149,756 277,075 202,649 107,536 126,096 -28.16%
Tax -24,536 -24,380 -34,332 -104,870 -86,596 -34,104 -34,784 -20.74%
NP 52,196 59,540 115,424 172,205 116,053 73,432 91,312 -31.09%
-
NP to SH 49,430 56,912 110,936 172,150 115,566 73,680 92,544 -34.14%
-
Tax Rate 31.98% 29.05% 22.93% 37.85% 42.73% 31.71% 27.59% -
Total Cost 3,478,413 3,387,012 3,733,272 4,642,810 5,355,009 3,867,812 3,082,684 8.37%
-
Net Worth 411,327 406,087 413,947 450,411 391,428 357,275 355,919 10.11%
Dividend
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Div 33,185 34,058 41,918 121,768 75,056 60,200 41,872 -14.34%
Div Payout % 67.14% 59.84% 37.79% 70.73% 64.95% 81.71% 45.25% -
Equity
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Net Worth 411,327 406,087 413,947 450,411 391,428 357,275 355,919 10.11%
NOSH 1,309,126 1,309,126 1,309,126 1,309,126 1,309,126 261,991 261,705 192.20%
Ratio Analysis
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
NP Margin 1.48% 1.73% 3.00% 3.58% 2.12% 1.86% 2.88% -
ROE 12.02% 14.01% 26.80% 38.22% 29.52% 20.62% 26.00% -
Per Share
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
RPS 269.52 263.10 293.80 367.74 417.92 301.16 1,212.81 -63.27%
EPS 3.77 4.34 8.48 13.15 8.83 5.64 35.36 -77.48%
DPS 2.53 2.60 3.20 9.30 5.73 4.60 16.00 -70.72%
NAPS 0.314 0.31 0.316 0.344 0.299 0.273 1.36 -62.33%
Adjusted Per Share Value based on latest NOSH - 1,309,336
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
RPS 244.97 239.14 267.04 334.08 379.60 273.46 220.22 7.35%
EPS 3.43 3.95 7.70 11.94 8.02 5.11 6.42 -34.13%
DPS 2.30 2.36 2.91 8.45 5.21 4.18 2.91 -14.50%
NAPS 0.2854 0.2818 0.2872 0.3125 0.2716 0.2479 0.247 10.10%
Price Multiplier on Financial Quarter End Date
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Date 30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 -
Price 0.515 0.595 0.755 0.74 0.835 5.29 3.26 -
P/RPS 0.19 0.23 0.26 0.20 0.20 1.76 0.27 -20.86%
P/EPS 13.65 13.70 8.92 5.63 9.46 93.96 9.22 29.86%
EY 7.33 7.30 11.22 17.77 10.57 1.06 10.85 -22.98%
DY 4.92 4.37 4.24 12.57 6.87 0.87 4.91 0.13%
P/NAPS 1.64 1.92 2.39 2.15 2.79 19.38 2.40 -22.40%
Price Multiplier on Announcement Date
30/09/22 30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 CAGR
Date 24/11/22 19/08/22 20/05/22 17/02/22 19/11/21 20/08/21 21/05/21 -
Price 0.55 0.595 0.72 0.76 0.845 0.925 4.03 -
P/RPS 0.20 0.23 0.25 0.21 0.20 0.31 0.33 -28.36%
P/EPS 14.58 13.70 8.50 5.78 9.57 16.43 11.40 17.80%
EY 6.86 7.30 11.76 17.30 10.45 6.09 8.77 -15.09%
DY 4.61 4.37 4.44 12.24 6.79 4.97 3.97 10.46%
P/NAPS 1.75 1.92 2.28 2.21 2.83 3.39 2.96 -29.53%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment